endothelial nitric oxide synthase gene therapy (AnGes)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameendothelial nitric oxide synthase gene therapy (AnGes)

Drug Alias NameN/A

ClassificationCell and gene therapy > Gene therapy

Mechanisms of ActionNitric-oxide synthase, endothelial stimulants

TargetsNitric-oxide synthase, endothelial

Therapy Area/IndicationsIschemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAnges Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAnges Inc

Active IndicationsN/A

Inactive IndicationsIschemia

ATC CodeN/A